241 related articles for article (PubMed ID: 16049338)
1. A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.
East E; Baker D; Pryce G; Lijnen HR; Cuzner ML; Gverić D
Am J Pathol; 2005 Aug; 167(2):545-54. PubMed ID: 16049338
[TBL] [Abstract][Full Text] [Related]
2. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice.
Teesalu T; Hinkkanen AE; Vaheri A
Am J Pathol; 2001 Dec; 159(6):2227-37. PubMed ID: 11733372
[TBL] [Abstract][Full Text] [Related]
3. Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation.
East E; Gverić D; Baker D; Pryce G; Lijnen HR; Cuzner ML
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):216-30. PubMed ID: 17983428
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage.
Gveric D; Hanemaaijer R; Newcombe J; van Lent NA; Sier CF; Cuzner ML
Brain; 2001 Oct; 124(Pt 10):1978-88. PubMed ID: 11571216
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
Akassoglou K; Kombrinck KW; Degen JL; Strickland S
J Cell Biol; 2000 May; 149(5):1157-66. PubMed ID: 10831618
[TBL] [Abstract][Full Text] [Related]
6. The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.
Gur-Wahnon D; Mizrachi T; Maaravi-Pinto FY; Lourbopoulos A; Grigoriadis N; Higazi AA; Brenner T
J Neuroinflammation; 2013 Oct; 10():124. PubMed ID: 24120085
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.
Bugge TH; Flick MJ; Danton MJ; Daugherty CC; Romer J; Dano K; Carmeliet P; Collen D; Degen JL
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5899-904. PubMed ID: 8650190
[TBL] [Abstract][Full Text] [Related]
8. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
9. Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.
Cunningham O; Campion S; Perry VH; Murray C; Sidenius N; Docagne F; Cunningham C
Glia; 2009 Dec; 57(16):1802-14. PubMed ID: 19459212
[TBL] [Abstract][Full Text] [Related]
10. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator receptor regulates leukocyte recruitment during experimental pneumococcal meningitis.
Paul R; Winkler F; Bayerlein I; Popp B; Pfister HW; Koedel U
J Infect Dis; 2005 Mar; 191(5):776-82. PubMed ID: 15688295
[TBL] [Abstract][Full Text] [Related]
12. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci; 2001 Jun; 21(12):4336-47. PubMed ID: 11404419
[TBL] [Abstract][Full Text] [Related]
13. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
14. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis.
Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W
FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088
[TBL] [Abstract][Full Text] [Related]
15. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System.
Merino P; Diaz A; Jeanneret V; Wu F; Torre E; Cheng L; Yepes M
J Biol Chem; 2017 Feb; 292(7):2741-2753. PubMed ID: 27986809
[TBL] [Abstract][Full Text] [Related]
17. Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis.
Lu W; Bhasin M; Tsirka SE
J Neurosci; 2002 Dec; 22(24):10781-9. PubMed ID: 12486171
[TBL] [Abstract][Full Text] [Related]
18. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
19. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.
Rakic JM; Lambert V; Munaut C; Bajou K; Peyrollier K; Alvarez-Gonzalez ML; Carmeliet P; Foidart JM; Noël A
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1732-9. PubMed ID: 12657615
[TBL] [Abstract][Full Text] [Related]
20. Expression of plasminogen activator and inhibitor, urokinase receptor and inhibin subunits in rhesus monkey testes.
Zhang T; Zhou HM; Liu YX
Mol Hum Reprod; 1997 Mar; 3(3):223-31. PubMed ID: 9237248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
